ANIP
Price
$67.98
Change
+$1.04 (+1.55%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
1.43B
35 days until earnings call
ORGO
Price
$4.28
Change
-$0.04 (-0.93%)
Updated
Apr 1, 04:59 PM (EDT)
Capitalization
374.78M
35 days until earnings call
Ad is loading...

ANIP vs ORGO

Header iconANIP vs ORGO Comparison
Open Charts ANIP vs ORGOBanner chart's image
ANI Pharmaceuticals
Price$67.98
Change+$1.04 (+1.55%)
Volume$8.01K
Capitalization1.43B
Organogenesis Holdings
Price$4.28
Change-$0.04 (-0.93%)
Volume$36.04K
Capitalization374.78M
ANIP vs ORGO Comparison Chart
Loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANIP vs. ORGO commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANIP is a StrongBuy and ORGO is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (ANIP: $66.95 vs. ORGO: $4.32)
Brand notoriety: ANIP and ORGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ANIP: 101% vs. ORGO: 84%
Market capitalization -- ANIP: $1.43B vs. ORGO: $374.78M
ANIP [@Pharmaceuticals: Other] is valued at $1.43B. ORGO’s [@Pharmaceuticals: Other] market capitalization is $374.78M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANIP’s FA Score shows that 0 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • ANIP’s FA Score: 0 green, 5 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, both ANIP and ORGO are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANIP’s TA Score shows that 7 TA indicator(s) are bullish while ORGO’s TA Score has 4 bullish TA indicator(s).

  • ANIP’s TA Score: 7 bullish, 3 bearish.
  • ORGO’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ANIP is a better buy in the short-term than ORGO.

Price Growth

ANIP (@Pharmaceuticals: Other) experienced а +1.47% price change this week, while ORGO (@Pharmaceuticals: Other) price change was -20.30% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.28%. For the same industry, the average monthly price growth was -2.37%, and the average quarterly price growth was +50.06%.

Reported Earning Dates

ANIP is expected to report earnings on May 07, 2025.

ORGO is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (-2.28% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANIP($1.43B) has a higher market cap than ORGO($375M). ANIP has higher P/E ratio than ORGO: ANIP (79.85) vs ORGO (70.25). ORGO YTD gains are higher at: 35.000 vs. ANIP (21.111). ANIP has higher annual earnings (EBITDA): 107M vs. ORGO (36M). ANIP has more cash in the bank: 221M vs. ORGO (104M). ORGO has less debt than ANIP: ORGO (119M) vs ANIP (286M). ANIP has higher revenues than ORGO: ANIP (487M) vs ORGO (433M).
ANIPORGOANIP / ORGO
Capitalization1.43B375M381%
EBITDA107M36M297%
Gain YTD21.11135.00060%
P/E Ratio79.8570.25114%
Revenue487M433M112%
Total Cash221M104M213%
Total Debt286M119M240%
FUNDAMENTALS RATINGS
ANIP vs ORGO: Fundamental Ratings
ANIP
ORGO
OUTLOOK RATING
1..100
2388
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
71
Overvalued
PROFIT vs RISK RATING
1..100
4695
SMR RATING
1..100
9291
PRICE GROWTH RATING
1..100
3936
P/E GROWTH RATING
1..100
927
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ORGO's Valuation (71) in the Financial Conglomerates industry is in the same range as ANIP (94) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to ANIP’s over the last 12 months.

ANIP's Profit vs Risk Rating (46) in the Pharmaceuticals Other industry is somewhat better than the same rating for ORGO (95) in the Financial Conglomerates industry. This means that ANIP’s stock grew somewhat faster than ORGO’s over the last 12 months.

ORGO's SMR Rating (91) in the Financial Conglomerates industry is in the same range as ANIP (92) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to ANIP’s over the last 12 months.

ORGO's Price Growth Rating (36) in the Financial Conglomerates industry is in the same range as ANIP (39) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to ANIP’s over the last 12 months.

ORGO's P/E Growth Rating (7) in the Financial Conglomerates industry is significantly better than the same rating for ANIP (92) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew significantly faster than ANIP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANIPORGO
RSI
ODDS (%)
Bearish Trend 2 days ago
68%
Bearish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
72%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
73%
Bullish Trend 14 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
70%
Bearish Trend 2 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 7 days ago
84%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bullish Trend 2 days ago
70%
N/A
View a ticker or compare two or three
Ad is loading...
ANIP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CADVX17.970.09
+0.50%
Calamos Dividend Growth A
FKUTX23.11N/A
N/A
Franklin Utilities A1
BMIIX6.93N/A
N/A
BNY Mellon Income Stock I
PMDHX17.84N/A
N/A
Principal Small-MidCap Dividend Inc R6
ARIQX9.91N/A
N/A
Aristotle Value Eq I

ANIP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANIP has been loosely correlated with ORGO. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANIP jumps, then ORGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANIP
1D Price
Change %
ANIP100%
-0.98%
ORGO - ANIP
43%
Loosely correlated
-4.00%
DRRX - ANIP
38%
Loosely correlated
+0.25%
PRGO - ANIP
35%
Loosely correlated
-0.07%
SNDL - ANIP
31%
Poorly correlated
-2.76%
PRPH - ANIP
29%
Poorly correlated
-8.11%
More

ORGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with PRGO. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then PRGO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
-4.00%
PRGO - ORGO
46%
Loosely correlated
-0.07%
ANIP - ORGO
43%
Loosely correlated
-0.98%
AMRX - ORGO
30%
Poorly correlated
+1.21%
ACET - ORGO
29%
Poorly correlated
-9.06%
AMPH - ORGO
27%
Poorly correlated
+1.97%
More